© Fairhursts. University of Cambridge Heart and Lung Research Institute landscape
The Heart and Lung Research Institute (HLRI) is a partnership with the Royal Papworth Hospital, which was officially opened by HM the Queen on 9 July, and forms part of the Cambridge Biomedical Campus, the centrepiece of the largest biotech cluster outside the United States of America.
It will be home to over 380 scientists and state-of-the-art laboratories in genomics, population sciences, research into cellular mechanisms of disease and translational science and will also include a special ten bed facility where the first-in-patient studies of new treatments can be conducted. The Institute has set an ambitious five-year target to demonstrate proof-of-concept for at least ten new drugs or diagnostic approaches in heart and lung diseases.
Ramboll has previously worked with the University of Cambridge to successfully deliver its Materials Science & Metallurgy building, Maxwell Centre and Cambridge Assessment, and is currently delivering Cavendish III and the Shared Facilities Hub. Ramboll was appointed by the University to provide civil and structural engineering services.
“This is an incredibly exciting project bringing together world-renowned expertise in cardiovascular and respiratory science at Cambridge University and clinical excellence at Royal Papworth Hospital” says Professor Nick Morrell from the University of Cambridge, Interim Director of the institute and a non-Executive Director of Royal Papworth Hospital.
Professor John Wallwork, Chairman of Royal Papworth Hospital, said: “The Heart and Lung Research Institute will mean new treatments will be created, tested and delivered to tackle the biggest causes of premature death in the world all on one site. This will be a huge step forward and demonstrates one of the reasons Royal Papworth Hospital moved to the Cambridge Biomedical Campus – to collaborate with the best researchers in the world to help to save lives. The importance of this building cannot be underestimated and I can’t wait to see how it will transform healthcare in the years to come.”
Iain Mitchell-Jones, Ramboll Director, said: “The Heart and Lung Institute is the latest specialist facility that Ramboll is delivering for the University of Cambridge. Utilising our extensive science and laboratory experience we have built on proven concepts to deliver the complex requirements that this life changing facility needs to drive forward heart and lung research.”
The award is one of 11 announced from flagship capital investment scheme the UK Research Partnership Investment Fund, totalling over £670m of new investment into UK research and innovation. It complements £10 million of funding committed to the institute by the British Heart Foundation (BHF). Further funding will be provided by the University and Royal Papworth Hospital, and the Wolfson Foundation.
Work on the HLRI will begin almost immediately, with ground-breaking taking place in November 2019 and construction starting in early 2020.
The new Materials Science & Metallurgy building at the University of Cambridge is one of the highest performing laboratory facilities in the world – a testament to the collaborative approach of the project team. Ramboll experts provided civil and structural engineering services for the project.
The £26 million Maxwell Centre is the latest science facility that Ramboll have been involved in for the University of Cambridge. The doubly-curved four storey steel structure provides a new home for “blue skies” physics research and industrial collaboration.
Cavendish III will be the new home of the Department of Physics at the University of Cambridge. The department has a long and distinguished history including 29 Nobel Laureates.
Construction is now complete at the new National Graphene Institute (NGI) a £61 million state-of-the-art facility at The University of Manchester, dedicated to the study, research and development of graphene and its applications.